67 related articles for article (PubMed ID: 27216059)
1. Phenotypic Screening In Vitro of Novel Aromatic Amidines against Trypanosoma cruzi.
Simões-Silva MR; Nefertiti AS; De Araújo JS; Batista MM; Da Silva PB; Bahia MT; Menna-Barreto RS; Pavão BP; Green J; Farahat AA; Kumar A; Boykin DW; Soeiro MN
Antimicrob Agents Chemother; 2016 Aug; 60(8):4701-7. PubMed ID: 27216059
[TBL] [Abstract][Full Text] [Related]
2. Activity of pyridyl-pyrazolone derivatives against Trypanosoma cruzi.
Batista DDGJ; de Almeida Fiuza LF; Klupsch F; da Costa KN; Batista MM; da Conceição K; Bouafia H; Vergoten G; Millet R; Thuru X; Bailly C; Soeiro MNC
Exp Parasitol; 2024 Jul; 262():108787. PubMed ID: 38759776
[TBL] [Abstract][Full Text] [Related]
3. Improving in vitro screening compounds anti-Trypanosoma cruzi by GFP-expressing parasites.
Delvoss CMM; Inoue AH; da Silva RV; Fragoso SP; Eger I
Mem Inst Oswaldo Cruz; 2024; 119():e230223. PubMed ID: 38716979
[TBL] [Abstract][Full Text] [Related]
4. Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones.
de Castro SL; Batista DG; Batista MM; Batista W; Daliry A; de Souza EM; Menna-Barreto RF; Oliveira GM; Salomão K; Silva CF; Silva PB; Soeiro Mde N
Mol Biol Int; 2011; 2011():306928. PubMed ID: 22091400
[TBL] [Abstract][Full Text] [Related]
5. Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease.
Sbaraglini ML; Bellera CL; Fraccaroli L; Larocca L; Carrillo C; Talevi A; Alba Soto CD
Int J Antimicrob Agents; 2016 Jul; 48(1):91-95. PubMed ID: 27216381
[TBL] [Abstract][Full Text] [Related]
6. Antiparasitic Activity of
Peres RB; Batista MM; Bérenger ALR; Camillo FDC; Figueiredo MR; Soeiro MNC
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242777
[TBL] [Abstract][Full Text] [Related]
7. Escaping ESKAPE resistance:
Gulia K; Hassan AHE; Lenhard JR; Farahat AA
R Soc Open Sci; 2023 Apr; 10(4):230020. PubMed ID: 37090961
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic Evaluation of Nucleoside Analogues against
Fiuza LFA; Batista DGJ; Girão RD; Hulpia F; Finamore-Araújo P; Aldfer MM; Elmahallawy EK; De Koning HP; Moreira O; Van Calenbergh S; Soeiro MNC
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432189
[TBL] [Abstract][Full Text] [Related]
9. Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in
Barbosa JMC; Pedra-Rezende Y; Pereira LD; de Melo TG; Barbosa HS; Lannes-Vieira J; de Castro SL; Daliry A; Salomão K
Front Cell Infect Microbiol; 2022; 12():975931. PubMed ID: 36093188
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Phenotypic Activity and In Silico Analysis of Natural Products from Brazilian Biodiversity on
Peres RB; Fiuza LFA; da Silva PB; Batista MM; Camillo FDC; Marques AM; de C Brito L; Figueiredo MR; Soeiro MNC
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577145
[TBL] [Abstract][Full Text] [Related]
11. Combination With Tomatidine Improves the Potency of Posaconazole Against
Rocha-Hasler M; de Oliveira GM; da Gama AN; Fiuza LFA; Fesser AF; Cal M; Rocchetti R; Peres RB; Guan XL; Kaiser M; Soeiro MNC; Mäser P
Front Cell Infect Microbiol; 2021; 11():617917. PubMed ID: 33747979
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect and ultrastructural changes in Trypanosoma cruzi caused by isoobtusilactone A in short exposure of time.
de Almeida JM; Nunes FO; Ceole LF; Klimeck TDF; da Cruz LA; Tófoli D; Borges BS; Garcez WS; Tozetti IA; Medeiros LCS; Garcez FR; Ferreira AMT
PLoS One; 2021; 16(1):e0245882. PubMed ID: 33507972
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrophthalazinone Inhibitor of Phosphodiesterase with
de Araújo JS; Peres RB; Bernardino da Silva P; Batista MM; Sterk GJ; Maes L; Caljon G; Leurs R; de Koning HP; Kalejaiye TD; Soeiro MNC
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361300
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi.
de Araújo JS; França da Silva C; Batista DDGJ; Nefertiti A; Fiuza LFA; Fonseca-Berzal CR; Bernardino da Silva P; Batista MM; Sijm M; Kalejaiye TD; de Koning HP; Maes L; Sterk GJ; Leurs R; Soeiro MNC
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601163
[TBL] [Abstract][Full Text] [Related]
15. Chagas Disease: Detection of
Kann S; Kunz M; Hansen J; Sievertsen J; Crespo JJ; Loperena A; Arriens S; Dandekar T
J Clin Med; 2020 May; 9(5):. PubMed ID: 32443464
[TBL] [Abstract][Full Text] [Related]
16. Imidazole Derivatives as Promising Agents for the Treatment of Chagas Disease.
de Araújo JS; García-Rubia A; Sebastián-Pérez V; Kalejaiye TD; Bernardino da Silva P; Fonseca-Berzal CR; Maes L; De Koning HP; Soeiro MNC; Gil C
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670432
[TBL] [Abstract][Full Text] [Related]
17. TrypanocidalActivity of Natural Sesquiterpenoids Involves Mitochondrial Dysfunction, ROS Production and Autophagic Phenotype in Trypanosomacruzi.
Bombaça ACS; Dossow DV; Barbosa JMC; Paz C; Burgos V; Menna-Barreto RFS
Molecules; 2018 Oct; 23(11):. PubMed ID: 30373326
[TBL] [Abstract][Full Text] [Related]
18. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
[TBL] [Abstract][Full Text] [Related]
19. Ergosterol isolated from the basidiomycete
Alexandre TR; Lima ML; Galuppo MK; Mesquita JT; do Nascimento MA; Dos Santos AL; Sartorelli P; Pimenta DC; Tempone AG
J Venom Anim Toxins Incl Trop Dis; 2017; 23():30. PubMed ID: 28572816
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
